Supporting Access to Eflornithine (Difluoromethylornithine (DFMO)) for public hospital patients with high-risk neuroblastoma

This Schedule provides time-limited funding to states and territories (States) to reimburse the cost of purchasing and transporting the medicine eflornithine (otherwise referred to as Difluroromethylornithine or DFMO) for eligible patients.

Supporting access to eflornithine

This Schedule provides time-limited funding to states and territories (States) to reimburse the cost of purchasing and transporting the medicine eflornithine (otherwise referred to as Difluroromethylornithine or DFMO) for eligible patients.